Get the Stockscreener App
123.95
4.70%
5.56
After Hours:
123.95
Overview
News
Price History
Option Chain
Financials
Why RVTY Down?
Discussions
Forecast
Stock Split
Dividend History
Revvity Inc stock is traded at $123.95, with a volume of 1.21M.
It is up +4.70% in the last 24 hours and up +10.12% over the past month.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
See More
Previous Close:
$118.39
Open:
$119.02
24h Volume:
1.21M
Relative Volume:
1.41
Market Cap:
$15.08B
Revenue:
$2.72B
Net Income/Loss:
$254.30M
P/E Ratio:
59.98
EPS:
2.0665
Net Cash Flow:
$564.37M
1W Performance:
+2.67%
1M Performance:
+10.12%
6M Performance:
+14.61%
1Y Performance:
+16.46%
1-Day Range:
$118.83
$124.04
1-Week Range:
$116.60
$124.04
52-Week Range:
$97.31
$129.50
Revvity Inc Stock (RVTY) Company Profile
Name
Revvity Inc
Sector
Industry
Phone
781-663-6900
Address
77 4TH AVENUE, WALTHAM
Compare RVTY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
123.95 | 15.08B | 2.72B | 254.30M | 564.37M | 2.0665 |
|
TMO
Thermo Fisher Scientific Inc
|
573.06 | 219.20B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
244.11 | 176.31B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
152.57 | 43.57B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
205.69 | 37.33B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
427.33 | 34.99B | 3.84B | 866.24M | 792.60M | 10.37 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-08-24 | Initiated | Leerink Partners | Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | UBS | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-23-23 | Resumed | Goldman | Buy |
View All
Revvity Inc Stock (RVTY) Latest News
Raymond James Lowers Revvity (NYSE:RVTY) Price Target to $140.00 - MarketBeat
Revvity Inc (RVTY) Shares Up 3.21% on Jan 21 - GuruFocus.com
Lentiviral Vectors Market Generated Opportunities, Future - openPR
Avanza Fonder AB Invests $898,000 in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Oak Thistle LLC Purchases Shares of 2,842 Revvity, Inc. (NYSE:RVTY) - MarketBeat
RVTY Stock Falls Despite FDA Nod for Automated Testosterone Test - MSN
Stocks Showing Improved Relative Strength: Revvity - MSN
Revvity, Inc. (NYSE:RVTY) Shares Purchased by Contravisory Investment Management Inc. - MarketBeat
Revvity Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Ex-Dividend Reminder: Revvity, Dime Community Bancshares and McGrath RentCorp - Nasdaq
Revvity’s Q4 2024 Earnings: What to Expect - Nasdaq
Neurogenomics Market Forecast and Trends Analysis to 2031: Healthcare Investments and Early Detection Drive Robust Uptake of Neurogenomics Solutions - GlobeNewswire Inc.
Revvity’s Q4 2024 Earnings: What To Expect - Barchart
Revvity to Seek M&A -January 13, 2025 at 11:15 am EST - Marketscreener.com
Revvity’s $1.5 Billion Syndicated Revolving Credit Facility - Global Legal Chronicle
Revvity (NYSE:RVTY) Shares Gap UpHere's What Happened - MarketBeat
Revvity to Announce Q4 and Full-Year 2024 Results - TipRanks
Revvity Partners with Element Biosciences to Transform Neonatal Genetic Testing - StockTitan
Revvity Announces FDA Clearance for First Automated Free Testosterone Test - Technology Networks
Revvity to Hold Earnings Call on Friday, January 31, 2025; Provides Update on Financial Performance - Business Wire
Revvity wins FDA clearance for ChLIA assay in free testosterone measurement - MSN
Revvity Wins FDA Nod for Automated Free Testosterone Test - MPO-mag
Bernstein revises Revvity stock outlook—can stability outweigh slowing growth? - Investing.com Nigeria
Revvity gets FDA clearance for first automated free testosterone test - MSN
Revvity (NYSE:RVTY) Downgraded by Sanford C. Bernstein to "Market Perform" - MarketBeat
Revvity, Inc. Announces Fda Clearance for First Automated Free Testosterone Test -January 10, 2025 at 08:00 am EST - Marketscreener.com
Bernstein revises Revvity stock outlook—can stability outweigh slowing growth? By Investing.com - Investing.com South Africa
RVTYRevvity, Inc. Latest Stock News & Market Updates - StockTitan
Revvity Secures FDA Clearance for First-Ever Automated Free Testosterone Test - StockTitan
Revvity (FRA:PKN) Earnings Yield (Joel Greenblatt) % : 1.99% (As of Sep. 2024) - GuruFocus.com
No time to waste: Revvity CFO Max Krakowiak - CFO.com
Revvity Inc. stock outperforms competitors despite losses on the day - MarketWatch
Revvity, Inc. (NYSE:RVTY) Insider Tajinder S. Vohra Sells 5,492 Shares - MarketBeat
Revvity secures new $1.5 billion credit facility By Investing.com - Investing.com Canada
Revvity, Inc. (RVTY) Secures New $1.5 Billion Unsecured Revolvin - GuruFocus.com
Revvity secures new $1.5 billion credit facility - Investing.com
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Shareholders Should Be Pleased With Revvity, Inc.'s (NYSE:RVTY) Price - Simply Wall St
Revvity, Inc. (NYSE:RVTY) Shares Purchased by JPMorgan Chase & Co. - MarketBeat
Revvity, Inc. (NYSE:RVTY) Shares Sold by Everence Capital Management Inc. - MarketBeat
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now - MSN
Revvity (FRA:PKN) Float Percentage Of Total Shares Outstanding : 75.15% (As of Dec. 30, 2024) - GuruFocus.com
Revvity Inc. stock underperforms Friday when compared to competitors - MarketWatch
(RVTY) Proactive Strategies - Stock Traders Daily
Is Revvity Stock Underperforming the S&P 500? - Nasdaq
Revvity Inc Stock (RVTY) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):